NovaQuest Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$48.8M Hold
3,474,645
89.99% 1
2020
Q2
$71.6M Hold
3,474,645
83.05% 1
2020
Q1
$26.2M Hold
3,474,645
74.74% 1
2019
Q4
$53.9M Hold
3,474,645
68.07% 1
2019
Q3
$18.1M Hold
3,474,645
47.14% 2
2019
Q2
$31.4M Hold
3,474,645
60.87% 1
2019
Q1
$82.9M Hold
3,474,645
77.15% 1
2018
Q4
$57M Buy
3,474,645
+2,286,284
+192% +$45.1M 64.51% 1
2018
Q3
$31.6M Hold
1,188,361
44.89% 2
2018
Q2
$27.2M Hold
1,188,361
38.83% 2
2018
Q1
$25.3M Hold
1,188,361
34.5% 2
2017
Q4
$15M Buy
+1,188,361
New +$15.9M 11.95% 2

Other funds holding MYOV

NovaQuest Capital Management's MYOV Position: Q3 2020 in Review

NovaQuest Capital Management held its Myovant Sciences Ltd. (MYOV) position steady in Q3 2020 at 3,474,645 shares worth $48.8M. The position accounts for 89.99% of the portfolio, ranked #1.

NovaQuest Capital Management first reported a position in MYOV in Q4 2017 and has held it in 12 quarters since. The position peaked at $82.9M in Q1 2019. 102 funds tracked by Wall St. Rank hold MYOV as of Q3 2020.

  • NovaQuest Capital Management held 3,474,645 shares of Myovant Sciences Ltd. worth $48.8M as of Q3 2020.
  • NovaQuest Capital Management left its Myovant Sciences Ltd. share count unchanged in Q3 2020.
  • Myovant Sciences Ltd. made up 89.99% of NovaQuest Capital Management's portfolio in Q3 2020, its #1 holding.
  • NovaQuest Capital Management first reported a position in Myovant Sciences Ltd. in Q4 2017 and has held it in 12 quarters since.
  • NovaQuest Capital Management's Myovant Sciences Ltd. position peaked at $82.9M in Q1 2019.
  • 102 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2020.

Based on NovaQuest Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.